TM6SF2 and metabolic dysfunction-associated steatotic liver disease: However, in contrast, Wong et al. [106] reported that the TM6SF2 rs58542926 variant did not contribute to the development of liver fibrosis or cirrhosis in Chinese individuals with NAFLD.